We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$222M
AUM Growth
-$20.6M
(-8.5%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-11.33%
Top 10 Holdings %
Top 10 Hldgs %
79.28%
Holding
47
New
3
Increased
16
Reduced
12
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$6.04M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.53M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$1.43M |
| 4 |
Invesco Senior Loan ETF
BKLN
|
+$1.17M |
| 5 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ImmunityBio
IBRX
|
+$26.5M |
| 2 |
Vanguard Total Bond Market
BND
|
+$6.18M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$719K |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$638K |
| 5 |
Global X MLP & Energy Infrastructure ETF
MLPX
|
+$494K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 100% |
| 2 | Healthcare | 0% |
Similar funds
MBA
SIA
AP
MW
SBIA
LC
TW
PAME
Callan Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Callan Capital held 47 positions worth $222M, down 8.5% from $243M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Callan Capital withdrew a net $25.2M in Q4 2016, closing 10 positions and reducing 12 holdings. Its most notable exit was ImmunityBio, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, up from 89% a quarter earlier, followed by Healthcare.
Against the trend, Callan Capital opened a new position in Vanguard Short-Term Bond ETF worth $6M.
- Callan Capital's largest Q4 2016 buy was Vanguard Short-Term Bond ETF: 75,546 shares worth $6M.
- Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q4 2016, an estimated $1.53M increase.
- Callan Capital's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $719K.
- Callan Capital fully exited ImmunityBio in Q4 2016, selling an estimated $26.5M.
- Callan Capital's ten largest holdings make up 79% of its $222M portfolio in Q4 2016.
- Callan Capital opened 3 new positions and closed 10 in Q4 2016.
- Callan Capital's portfolio value fell 8.5% quarter-over-quarter to $222M.
Based on Callan Capital's 13F filing for Q4 2016, filed 9 Feb 2017.